StockDrifts LogoStockDrifts

Kalehua Capital Management 13F Portfolio

Portfolio Manager
Kalehua Capital Management LLC
Performance
+33.35% (2026 Q2)
AUM (13F)
$139.53M
# of Holdings
23
Performance Rank
N/A
Allocation (Top 20)
98.36%
Latest filing
Q2 2026

Kalehua Capital Management LLC Holdings Map

Top 23 Kalehua Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
MANE
Veradermics Inc
12.84%145.7K$17.9M
+41.62%(+42.82K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 102.9K shares2026-Q2: 145.7K shares
$71.60(+50.73%)
2026-06-30
XFOR
X4 Pharmaceuticals Inc
12.46%3.72M$17.4M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 3.72M shares2026-Q1: 3.72M shares2026-Q2: 3.72M shares
$3.71(+15.63%)
2026-06-30
CMPS
Compass Pathways Plc
8.31%819.7K$11.6M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 819.7K shares2026-Q1: 819.7K shares2026-Q2: 819.7K shares
$6.32(+121.38%)
2026-06-30
SRZN
Surrozen Inc
7.16%385.2K$10.0M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 385.2K shares2026-Q1: 385.2K shares2026-Q2: 385.2K shares
$17.74(+33.75%)
2026-06-30
ACRS
Aclaris Therapeutics Inc
6.95%1.83M$9.7M
+36.99%(+494.81K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 1.34M shares2026-Q2: 1.83M shares
$3.65(+60.43%)
2026-06-30
SION
Sionna Therapeutics Inc
6.21%197.1K$8.7M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 197.1K shares2026-Q1: 197.1K shares2026-Q2: 197.1K shares
$35.27(-82.27%)
2026-06-30
IKT
Inhibikase Therapeutics Inc
5.56%3.82M$7.8M
+43.00%(+1.15M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.75M shares2026-Q1: 2.67M shares2026-Q2: 3.82M shares
$1.83(+32.01%)
2026-06-30
PHVS
Pharvaris NV
4.93%198.8K$6.9M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 198.8K shares2026-Q1: 198.8K shares2026-Q2: 198.8K shares
$26.35(+29.18%)
2026-06-30
KPTI
Karyopharm Therapeutics Inc
4.8%685.6K$6.7Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 685.6K shares
$7.54(-73.99%)
2026-06-30
SEPN
Septerna Inc
4.67%194.5K$6.5M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 194.5K shares2026-Q1: 194.5K shares2026-Q2: 194.5K shares
$23.34(+103.79%)
2026-06-30

About Kalehua Capital Management LLCโ€™s portfolio

Kalehua Capital Management LLC reports $139.53M in US-listed equity holdings across 23 positions in its most recent 13F filing. Its largest disclosed positions are MANE (12.8%), XFOR (12.5%) and CMPS (8.3%). The top 20 holdings account for 98.36% of reported assets. Its disclosed equity book has returned +43.70% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
MANE โ€” 12.8% ($17.91M)XFOR โ€” 12.5% ($17.39M)CMPS โ€” 8.3% ($11.60M)SRZN โ€” 7.2% ($10.00M)ACRS โ€” 6.9% ($9.69M)SION โ€” 6.2% ($8.67M)IKT โ€” 5.6% ($7.76M)PHVS โ€” 4.9% ($6.87M)KPTI โ€” 4.8% ($6.70M)SEPN โ€” 4.7% ($6.52M)Other โ€” 26.1% ($36.43M)
74%in top 10
  • MANE12.8%
  • XFOR12.5%
  • CMPS8.3%
  • SRZN7.2%
  • ACRS6.9%
  • SION6.2%
  • IKT5.6%
  • PHVS4.9%
  • KPTI4.8%
  • SEPN4.7%
  • Other26.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
7
KPTIKaryopharm Therapeutics Inc4.8%
IFRXInflarx Nv4.7%
CYCNCyclerion Therapeutics Inc4.0%
NVCTNuvectis Pharma Inc1.3%
+3 opened
Added to
4
MANEVeradermics Inc+41.6%
ACRSAclaris Therapeutics Inc+37.0%
IKTInhibikase Therapeutics Inc+43.0%
GOSSGossamer Bio Inc+49.2%
Trimmed
2
QUREUniqure Nv-62.5%
TILInstil Bio Inc-28.8%

Unlock alerts, watchlists & AI chat

Sign up free to track Kalehua Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Kalehua Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2106181). View Kalehua Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all